Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $165.4000 (1.03%) ($163.2600 - $165.5300) on Wed. Dec. 7, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.57% (three month average) | RSI | 89 | Latest Price | $165.4000(1.03%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 0.5% a day on average for past five trading days. | Weekly Trend | ABBV advances 2.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XBI(12%) XLV(12%) DIA(10%) MCHI(10%) EDOC(9%) | Factors Impacting ABBV price | ABBV will decline at least -0.785% in a week (0% probabilities). VIXM(-10%) UUP(-7%) JETS(-6%) IWN(-6%) IWC(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.785% (StdDev 1.57%) | Hourly BBV | 1.4 () | Intraday Trend | 1% | | | |
|
5 Day Moving Average | $163.67(1.06%) | 10 Day Moving Average | $161.66(2.31%) | 20 Day Moving Average | $157.49(5.02%) | To recent high | 0% | To recent low | 23.2% | Market Cap | $291.812b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |